Table 3.
25 most relevant pathways over-represented in reactome analysis.
Entities |
Reactions |
|||
---|---|---|---|---|
Pathway name | Found/total | p value | FDR | Found/total |
Formation of the ternary complex, and subsequently, the 43S complex | 35/52 | 1.11E-16 | 4.11E-15 | 3/3 |
Translation initiation complex formation | 39/59 | 1.11E-16 | 4.11E-15 | 2/2 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 39/60 | 1.11E-16 | 4.11E-15 | 6/6 |
Ribosomal scanning and start codon recognition | 38/59 | 1.11E-16 | 4.11E-15 | 2/2 |
AUF1 (hnRNP D0) binds and destabilizes mRNA | 36/56 | 1.11E-16 | 4.11E-15 | 4/4 |
Peptide chain elongation | 57/90 | 1.11E-16 | 4.11E-15 | 5/5 |
Eukaryotic Translation Elongation | 59/95 | 1.11E-16 | 4.11E-15 | 9/9 |
Formation of a pool of free 40S subunits | 63/102 | 1.11E-16 | 4.11E-15 | 2/2 |
Eukaryotic Translation Termination | 57/94 | 1.11E-16 | 4.11E-15 | 5/5 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 58/96 | 1.11E-16 | 4.11E-15 | 1/1 |
GTP hydrolysis and joining of the 60S ribosomal subunit | 68/113 | 1.11E-16 | 4.11E-15 | 3/3 |
Cap-dependent Translation Initiation | 69/120 | 1.11E-16 | 4.11E-15 | 18/18 |
Viral mRNA Translation | 55/101 | 1.11E-16 | 4.11E-15 | 2/2 |
Nonsense-Mediated Decay (NMD) | 60/117 | 1.11E-16 | 4.11E-15 | 6/6 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 60/117 | 1.11E-16 | 4.11E-15 | 5/5 |
SRP-dependent co-translational protein targeting to membrane | 55/113 | 1.11E-16 | 4.11E-15 | 5/5 |
Neutrophil degranulation | 144/480 | 1.11E-16 | 4.11E-15 | 10/10 |
Eukaryotic Translation Initiation | 69/120 | 1.11E-16 | 4.11E-15 | 20/21 |
Membrane Trafficking | 141/635 | 1.11E-16 | 4.11E-15 | 169/218 |
Vesicle-mediated transport | 177/761 | 1.11E-16 | 4.11E-15 | 191/251 |
RHO GTPase Effectors | 83/295 | 1.11E-16 | 4.11E-15 | 85/112 |
ER-Phagosome pathway | 60/153 | 1.11E-16 | 4.11E-15 | 7/10 |
L13a-mediated translational silencing of Ceruloplasmin expression | 69/112 | 1.11E-16 | 4.11E-15 | 2/3 |
Antigen processing-Cross presentation | 62/169 | 1.11E-16 | 4.11E-15 | 14/22 |
Translation | 94/294 | 1.11E-16 | 4.11E-15 | 61/99 |